Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand

Type distribution of human papillomavirus among adult women diagnosed with invasive cervical cancer (stage 1b or higher) in New Zealand

(2014) Peter Sykes et al.   BMC INFECTIOUS DISEASES

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds

(2014) Henry C Kitchener et al.   HEALTH TECHNOLOGY ASSESSMENT

Incremental Benefits of Male HPV Vaccination: Accounting for Inequality in Population Uptake

(2014) Megan A. Smith et al.   PLoS One

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial

(2014) K. M. Elfstrom et al.   BMJ-British Medical Journal

Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand

(2013) Leonardo M Simonella et al.   BMC INFECTIOUS DISEASES

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

Expenditure and resource utilisation for cervical screening in Australia

(2012) Jie-Bin Lew et al.   BMC HEALTH SERVICES RESEARCH

Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway

(2012) E A Burger et al.   BRITISH JOURNAL OF CANCER

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study

(2012) R. Legood et al.   BMJ-British Medical Journal

Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program

(2011) Suzanne M Garland et al.   BMC Medicine

A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial

(2011) Henry C. Kitchener et al.   EUROPEAN JOURNAL OF CANCER

Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies

(2011) Karen Canfell et al.   VACCINE

Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years

(2010) Prudence Creighton et al.   BMC PUBLIC HEALTH

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

Liquid Compared With Conventional Cervical Cytology

(2010) Marc Arbyn et al.   OBSTETRICS AND GYNECOLOGY

The predicted impact of vaccination on human papillomavirus infections in Australia

(2008) Megan A. Smith et al.   INTERNATIONAL JOURNAL OF CANCER

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

(2008) Margaret RE McCredie et al.   LANCET ONCOLOGY